Angiotensin-converting enzyme gene polymorphism in children with idiopathic nephrotic syndrome

American Journal of Nephrology

Volumn 26, Issue 2, 2006, Pages 157-162

  Tsai, I Jung ^a   Yang, Yao Hsu ^a   Lin, Yen Hung ^a   Wu, Vin Cent ^a   Tsau, Yong Kwei ^a   Hsieh, Fon Jou ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Angiotensin converting enzyme gene polymorphism; Nephrotic syndrome; Steroid dependence

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; PREDNISOLONE; STEROID;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DRUG RESPONSE; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ANALYSIS; GENOTYPE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; STATISTICAL SIGNIFICANCE; STEROID THERAPY;

ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENOTYPE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INFANT; MALE; NEPHROTIC SYNDROME; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PREDNISOLONE; PROTEINURIA; TAIWAN;

EID: 33745110677     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092982     Document Type: Article

References (33)

1. A Report of the International Study of Kidney Disease in Children: Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 1978;13:159-165.
2. Barratt TM, Clark AG: Steroid-responsive nephrotic syndrome; in Barratt TM, Avner ED, Harmon WE (eds): Pediatric Nephrology. Baltimore, Lippincott /Williams & Wilkins, 1999, pp 731-746.
3. Schwartz MM, Korbet SM: Primary focal segmental glomerulosclerosis: pathology, histologic variants, and pathogenesis. Am J Kidney Dis 1993;22:874-883.
4. Korbet SM, Schwartz MM, Lewis EJ: Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis 1994;23:773-783.
5. Haack D, Schärer K, Asam-Tauscher A, Vecsei P: Glucocorticoid receptors in idiopathic nephrotic syndrome. Pediatr Nephrol 1999;13:653-656.
6. Takeda A, Ohugushi H, Niimura F, Matsutani H: Long-term effects of immunosuppressants in steroid-dependent nephrotic syndrome. Pediatr Nephrol 1998;12:746-750.
7. Bagga A, Sharma A, Srivastava RN: Levamisole therapy in corticosteroid dependent nephrotic syndrome. Pediatr Nephrol 1997;11:415-417.
8. Eisenbach GM, Van Liew JB, Boylan JW, Manz N, Muir P: Effect of angiotensin on the filtration of protein in the rat kidney: a micropuncture study. Kidney Int 1975;8:80-87.
9. Bohrer MP, Deen WM, Robertson CR, Brenner BM: Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol 1977;233:F13-F21.
10. White CT, Macpheron CF, Hurley RM, Matsell DG: Antiproteinuric effects of enalapril and losartan: a pilot study. Pediatr Nephrol 2003;18:1038-1043.
11. Butani L: Remission of membranoproliferative nephritis with angiotensin converting enzyme inhibition and receptor blockade. Pediatr Nephrol 2003;18:1199.
12. Villard E, Soubrier F: Molecular biology and genetic of the angiotensin-I-converting enzyme gene: potential implication in cardiovascular diseases. Cardiovasc Res 1996;32:999-1007.
13. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644.
14. Marian AJ, Yu QT, Workman R, Greve G, Roberts R: Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993;342:1085-1086.
15. Hohenfellner K, Hunley TE, Brezinska R, Brodhag P, Shyr Y, Brenner W, Habermehl P, Kon V: ACE I/D gene polymorphism predicts renal damage in congenital uropathies. Pediatr Nephrol 1999;13:514-518.
16. Harden PN, Geddes C, Rowe PA, McIlroy JH, Boulton-Jones M, Rodger RS, Junor BJ, Briggs JD, Connell JM, Jardine AG: Polymorphisms in angiotensin converting enzyme gene and progression of IgA nephropathy. Lancet 1995;345:1540-1542.
17. Papp F, Friedman AL, Bereczki C, Haszon I, Kiss E, Endreffy E, Turi S: Renin-angiotensin gene polymorphism in children with uremia and essential hypertension. Pediatr Nephrol 2003;18:150-154.
18. Al-Eisa A, Haider MS, Srivastava BS: Angiotensin converting enzyme gene insertion/deletion polymorphism in idiopathic nephrotic syndrome in Kuwaiti Arab children. Scand J Urol Nephrol 2001;35:239-242.
19. Lee DY, Kim W, Kan SK, Koh GY, Park SK: Angiotensin-converting enzyme gene polymorphism in patients with minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Nephron 1997;77:471-473.
20. Oktem F, Sirin A, Bilge I, Emre S, Agachan B, Ispir T: ACE I/D gene polymorphism in primary FSGS and steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2004;19:384-389.
21. Dixit M, Mansur A, Dixit N, Gilman J, Santarina L, Glicklich D: The role of ACE gene polymorphism in rapidity of progression of focal segmental glomerulosclerosis. J Postgrad Med 2002;48:266-269.
22. Frishberg Y, Becker-Cohen R, Halle D, Feigin E, Eisenstein B, Halevy R, Lotan D, Juabeh I, Ish-Shalom N, Magen D, Shvil Y, Sinai-Treiman L, Drukker A: Genetic polymorphisms of the renin-angiotensin system and the outcome of focal segmental glomerulosclerosis in children. Kidney Int 1998;54:1843-1849.
23. Sambrook J, Fritisch F, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2. New York, Cold Spring Harbor Laboratory, 1989.
24. Gross E, Arnold N, Goette J, Schwarz-Boeger U, Kiechle M: A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet 1999;105:72-78.
25. O'Donovan MC, Oefner PJ, Roberts SC, Austin J, Hoogendoorn B, Guy C, Speight G, Upadhyaya M, Sommer SS, McGuffin P: Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics 1998;52:44-49.
26. Navis G, van der Kleij FG, de Zeeuw D, de Jong PE: Angiotensin-converting enzyme gene I/D polymorphism and renal disease. J Mol Med 1999;77:781-791.
27. Maruyama K, Yoshida M, Nishio H, Shirakawa T, Kawamura T, Tanaka R, Nakamura H, Iijima K, Yoshikawa N: Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol 2001;16:350-355.
28. Fogo A, Hawkins EP, Berry PL, Glick AD, Chiang ML, MacDonell RC Jr, Ichikawa I: Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerulosclerosis. Kidney Int 1990;38:115-123.
29. Matusaka T, Hymes J, Ichikawa I: Angiotensin in progressive renal diseases: theory and practice. J Am Soc Nephrol 1996;7:2025-2043.
30. Vleming LJ, van Kooten C, van Dijk M, Hollander DA, Paape ME, Westendorp RG, van Es LA: The D-allele of the ACE gene polymorphism predicts a stronger antiproteinuric response to ACE inhibitors. Nephrology 1998;4:143-149.
31. Caridi G, Bertelli R, Carrea A: Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 2001;12:2742-2746.
32. Mcc Bryde KD, Kershaw DB, Smoyer WE: Pediatric steroid-resistant nephrotic syndrome. Curr Probl Pediatr 2001;31:280-307.
33. Querfeld U: Should hyperlipidemia in children with nephrotic syndrome be treated? Pediatr Nephrol 1999;13:77-84.